首站-论文投稿智能助手
典型文献
Analysis on Clinical Characteristics and Combination Medications of Elemene Injection in the Treatment of Esophageal Cancer in Real World Research
文献摘要:
Objective: To explore the clinical characteristics of Elemene Injection in the treatment of patients with esophageal cancer. Methods: A total of 310 patients diagnosed with esophageal cancer from the Hoptital Information System (HIS) of 21 hospitals across the country were selected in the study, and these patients all had been treated with Elemene Injection. In this study, the clinical general medication record information, diagnosis scheme information, general treatment information and combined medications information were analyzed by frequency statistics and association rules. Results: Elemene Injection was used most in patients aged 46-65 (177 cases, 57.10%); male patients were more than female. Among the main diagnoses of the most seasons and solar terms in hospitalization, the top three diagnoses were esophageal malignant tumor, malignant tumor, and hypertension. In terms of combination medication, the combination of western medicine blood substitutes and perfusion fluids, general nutritional drugs, vitamins, antibacterial drugs, and immune-promoting drugs were the main ones; the combination of traditional Chinese medicine was mainly anti-tumor drugs (48.71%). In addition, among the combination medications, the highest frequency of Elemene Injection combined with western medicine and traditional Chinese medicine were Xiaoaiping Injection (消癌平注射液) and ascorbic acid. Conclusion: The main susceptible people of esophageal cancer was middle-aged around 46-65, and there were more male patients than female; through the first diagnosis of western medicine, it can be found that in addition to patients suffering from esophageal cancer or other cancers, patients with high blood pressure, heart disease, and diabetes could use Elemene Injection. Therefore, when receiving such patients, attention should be paid to checking whether the patient had such diseases. At the same time, when using Elemene Injection, it's necessary to pay attention to certain combined medications to avoid adverse reactions.
文献关键词:
作者姓名:
SHI Pu-wen;ZHAO Xiao-xiao;XIE Yan-ming;YU Xiao-kang
作者机构:
Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China;School of Statistics,Renmin University of China,Beijing 100872,China
引用格式:
[1]SHI Pu-wen;ZHAO Xiao-xiao;XIE Yan-ming;YU Xiao-kang-.Analysis on Clinical Characteristics and Combination Medications of Elemene Injection in the Treatment of Esophageal Cancer in Real World Research)[J].世界中西医结合杂志(英文),2022(03):1-8
A类:
Medications,Elemene,Hoptital,Xiaoaiping
B类:
Analysis,Clinical,Characteristics,Combination,Injection,Treatment,Esophageal,Cancer,Real,World,Research,Objective,To,explore,clinical,characteristics,treatment,patients,esophageal,Methods,total,diagnosed,from,Information,System,HIS,hospitals,across,country,were,selected,study,these,all,had,been,treated,this,general,record,information,diagnosis,scheme,combined,medications,analyzed,by,frequency,statistics,association,rules,Results,was,used,most,aged,cases,more,than,female,Among,diagnoses,seasons,solar,terms,hospitalization,top,three,malignant,tumor,hypertension,combination,western,medicine,blood,substitutes,perfusion,fluids,nutritional,drugs,vitamins,antibacterial,immune,promoting,ones,traditional,Chinese,mainly,addition,among,highest,注射液,ascorbic,acid,Conclusion,susceptible,people,middle,around,there,through,first,found,that,suffering,other,cancers,pressure,heart,diabetes,could,Therefore,when,receiving,such,attention,should,paid,checking,whether,diseases,At,same,using,necessary,pay,certain,avoid,adverse,reactions
AB值:
0.475044
相似文献
A Case Series of Olfactory Dysfunction in Imported COVID-19 Patients: A 12-Month Follow-Up Study
WANG Ni;YANG Ming Bo;YANG Pu Ye;CHEN Ren Bo;HUANG Fei;SHI Nan Nan;MA Yan;ZHANG Yan;XU You;LIU Si Hong;LU Heng Yi;FU Qing Qing;FAN Yi Pin;KAN Hong Min;WANG Xiao Hong;GUO Ya Ling-National Center for Tuberculosis Control and Prevention,Chinese Center for Disease Control and Prevention, Beijing 102206,China;Hepatology Department of TCM,Xi'an NO.8 Hospital,Xi'an 710061,Shaanxi,China;Department of Integrated Chinese and Western Medicine,Xi'an NO.8 Hospital,Xi'an 710061,Shaanxi,China;Department of Infection,Xi'an NO.8 Hospital,Xi'an 710061,Shaanxi,China;Institute of Information on Traditional Chinese Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China;Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences,Beijing 100700, China
A trial of arbidol hydrochloride in adults with COVID-19
Zhao Jingya;Zhang Jinnong;Jin Yang;Tang Zhouping;Hu Ke;Sun Hui;Shi Mengmeng;Yang Qingyuan;Gu Peiyu;Guo Hongrong;Li Qi;Zhang Haiying;Li Chenghong;Yang Ming;Xiong Nian;Dong Xuan;Xu Juanjuan;Lin Fan;Wang Tao;Yang Chao;Huang Bo;Zhang Jingyi;Chen Shi;He Qiong;Zhou Min;Qu Jieming-Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China;Institute of Respiratory Diseases, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China;Department of Emergency, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430058, China;Department of Respiratory and Critical Care Medicine, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430058, China;Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China;Department of Respiratory and Critical Care Medicine, Renmin Hospital, Wuhan University, Wuhan, Hubei 430060, China;Department of Endocrinology, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430058, China;Department of Respiratory Medicine, Wuhan Bauhinia Hospital, Wuhan, Hubei 430062, China;Department of Respiratory Medicine, Guanggu Hospital District, The Third Hospital of Wuhan, Wuhan, Hubei 430074, China;Department of Respiratory and Critical Care Medicine, Puren Hospital, Wuhan University of Science and Technology, Wuhan, Hubei 430081, China;Department of Respiratory Medicine, The Third People’s Hospital of Hubei Province, Wuhan, Hubei 430030, China;Department of Respiratory Medicine, The Sixth General Hospital of Hubei Province, Wuhan, Hubei 430015, China;Tuberculosis Department of Chengdu Public Health Clinical Medical Center, Chengdu, Sichuan 610066, China;Department of Neurology, Wuhan Red Cross Hospital, Wuhan, Hubei 430015, China;Department of Tuberculosis, Jinyintan Hospital, Wuhan, Hubei 430048, China;Department of Cardiology, The Third People’s Hospital of Hubei Province, Wuhan, Hubei 430030, China
Tongue and pulse features of 668 asymptomatic patients infected with the severe acute respiratory syndrome coronavirus 2 omicron variant in Shanghai
ZHANG Wen;CAO Min;SUN Ding;SHI Li;LU Wei;XU Xiangru;ZHOU Shuang;FANG Bangjiang-Department of Emergency,Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China;Department of Rheumatology,Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China;Department of Pediatrics,Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China;Department of Nursing,Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China;College of Acumox and Tuina,Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Institute of Emergency and Critical Care Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China
Pathological Change of Chronic Hepatitis B Patients with Different Tongue Coatings by Circular Multi-omics Integrated Analysis
TANG Yi-shuang;GUO Jian-chun;XU Lin;ZHANG Xiao-na;SHEN Xiao-ping;HAI Ya-mei;MAO Yu-feng;HU Yi-yang;ZHAO Yu-Key Laboratory of Liver and Kidney Diseases,Institute of Liver Diseases,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 201203 ,China;Department of Integrated Chinese and Western Medicine,Hangzhou Xixi Hospital,Hangzhou 310023 ,China;National Engineering Center for Biochip at Shanghai,Shanghai 201203 ,China;Institute of Clinical Pharmacology,Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 201203 ,China;Shanghai Key Laboratory of Traditional Chinese Clinical Medicine,Shanghai 201203 ,China
Data Mining and Systems Pharmacology to Elucidate Effectiveness and Mechanisms of Chinese Medicine in Treating Primary Liver Cancer
ZHANG Zhen;LI Jun-wei;ZENG Pu-hua;GAO Wen-hui;TIAN Xue-fei-Department of Internal Medicine,College of Integrated Chinese and Western Medicine of Hunan University of Chinese Medicine,Changsha,410208,China;Hunan Key Laboratory of TCM Prescription and Syndromes Translational Medicine,Hunan University of Chinese Medicine,Changsha,410208,China;Department of Pharmacy,Shenzhen People's Hospital,the Second Clinical Medical College,Jinan University;the First Affiliated Hospital,Southern University of Science and Technology,Shenzhen,518020,Guangdong Province, China;Department of Oncology,Affiliated Hospital of Hunan Academy of Traditional Chinese Medicine,Changsha,410006, China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。